CAPR Capricor Therapeutics Inc

Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.

$3.68
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/24/2002
Outstanding shares:  24,324,156
Average volume:  140,048
Market cap:   $84,891,304
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -8.18
PB ratio:   3.63
PS ratio:   -2,092.41
Return on equity:   -10.90%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy